 |
Article Review/Hyperlink |
Poynard T, Marcellin P, Lee SS, et al for the International Hepatitis Interventional Therapy Group
Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
Lancet (Oct) 351:1426-1432 1998
The abstract of this paper is available from the National Library of Medicine's PubMed site: click here .
| Related Folders: |
|
|
